Eptifibatide acetate is a cyclic heptapeptide and a glycoprotein IIb/IIIa inhibitor used as an antiplatelet drug. It works by reversibly binding to platelets, preventing their aggregation, which reduces the risk of acute cardiac ischemic events including myocardial infarction and unstable angina, especially in patients undergoing percutaneous coronary intervention (PCI) or receiving conservative medical treatment. It is grouped under the following drug class(es): Peptides. Its therapeutic use is listed as cardiovascular and hematologic agents. The directory classifies it as a commercial API with a peptide source/manufacturing origin. Other names for this substance include Eptifibatide (acetate) and Eptifibatide acetate – Bio-X. Its PubChem CID is 12001375.
Eptifibatide acetate
| CAS No | 148031-34-9 |
|---|---|
| Molecular Formula | C37H53N11O11S2 |
| Molecular Weight | 892.0 g/mol |
| Synonyms | acetic acid;2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Eptifibatide acetate is a cyclic heptapeptide and a glycoprotein IIb/IIIa inhibitor used as an antiplatelet drug.
The listed CAS number is 148031-34-9.
The listed molecular formula is C37H53N11O11S2.
The listed molecular weight is 892.0 g/mol.
acetic acid;2-[(3S,6S,12S,20R,23S)-20-carbamoyl-12-[4-(diaminomethylideneamino)butyl]-3-(1H-indol-3-ylmethyl)-2,5,8,11,14,22-hexaoxo-17,18-dithia-1,4,7,10,13,21-hexazabicyclo[21.3.0]hexacosan-6-yl]acetic acid.
The source lists Eptifibatide (acetate) and Eptifibatide acetate - Bio-X.